The Access to Cannabis for Medical Purposes Regulations (ACMPR) are the rules that govern Canada’s medical cannabis program. Instituted in the summer of 2016, the ACMPR outline the particulars of patient access, the principle role of licensed producers (LPs), and the transitional provisions added to, and subtracted from, the country’s former regulatory systems.
Introduced by the Liberal government of Justin Trudeau shortly after the Canadian prime minister’s improbable election victory in the fall of 2015, the Cannabis Act was recently approved by the Senate. If, as is projected, Bill C-45 becomes law, Canada will become the first G7 nation to legalize recreational cannabis at the federal level.
Please read all articles before taking the test and earning your points.